Ligand id: 7985

Name: durvalumab

Compound class Antibody
International Nonproprietary Names
INN number INN
10010 durvalumab
anti-B7H1 monoclonal antibody
Database Links
Specialist databases
IMGT/mAb-DB 528
Other databases
Search PubMed clinical trials durvalumab
Search PubMed titles durvalumab
Search PubMed titles/abstracts durvalumab
Wikipedia Durvalumab
Durvalumab is a monoclonal antibody directed against programmed death-1 ligand-1 (PD-L1, aka CD274), an important immunopharmacological drug discovery target in immuno-oncology.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. A patent search suggests that the development and use of durvalumab may be covered by patent WO2011066389 [1], although we cannot verify this by peptide sequence matches as no sequences from this patent are pulled in a protein BLAST with the light or heavy variable regions of durvalumab peptide sequences.